Dogs bark, but the caravan goes on: A discussion on the meta-analysis of antidepressants by Andrea Cipriani et al.

The International Journal of Risk & Safety in Medicine
Tomaž Makovec

Abstract

In the case of depression (and other psychiatric disorders), a huge number of scientists have been trying for decades to establish and postulate the disease-based drug concept for antidepressants and these efforts have not born fruits. To show that the discussions about statistical significance of the efficiency of the antidepressants over placebo are non-productive and irrelevant. Researching the history of the onset of a chemical imbalance theory in the brain and the launch of antidepressants according to the drug-based disease model was the basis for doubting the appropriateness of using antidepressants in the treatment of depression. Antidepressants (AD), as their name suggests, are supposed to address a disease-specific model to reverse the neuropathological basis of depression. However, science has not constituted the theory, using various brain imagining techniques or measuring the concentration of serotonin in various body liquids, that depression is characterized by the lack of serotonin in synapses and then created a substance that would block the reuptake of this neurotransmitter or in some other ways elevate its content. Even the reductionistic phase of the AD story, the mechanism of action, failed to be consistent ...Continue Reading

References

Dec 1, 1967·The British Journal of Psychiatry : the Journal of Mental Science·D M ShawE G Eccleston
Jul 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W A Brown
Jul 22, 2004·JAMA : the Journal of the American Medical Association·Hershel JickSusan S Jick
May 9, 2007·The New England Journal of Medicine·Richard A Friedman, Andrew C Leon
Mar 7, 2008·Social Science & Medicine·Joanna Moncrieff
Aug 28, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S EversUNKNOWN European Federation of Neurological Societies
Sep 17, 2010·The American Journal of Psychiatry·Vaishnav Krishnan, Eric J Nestler
Apr 20, 2011·British Journal of Clinical Pharmacology·Silvia RaveraLolkje T W de Jong-van den Berg
Sep 14, 2012·British Journal of Clinical Pharmacology·Chia-Ming ChangHui-Ju Tsai
May 3, 2013·PloS One·Espen Jimenez-SolemHenrik Enghusen Poulsen
Jun 17, 2014·Maturitas·Sophia Bennett, Alan J Thomas
Jul 18, 2015·The Annals of Pharmacotherapy·Jessica M Hawthorne, Charles F Caley
Sep 30, 2016·Psychiatry and Clinical Neurosciences·Glenda M MacQueen, Katherine A Memedovich
Dec 9, 2016·Current Neuropharmacology·Haitham SalemAntonio Lucio Teixeira
Aug 10, 2017·Current Psychiatry Reports·Adam WichniakWojciech Jernajczyk
Feb 27, 2018·Psychopharmacology·Arif KhanWalter A Brown
Apr 21, 2018·Frontiers in Pharmacology·Andria L Del TrediciTanya A Moreno
May 26, 2018·BMJ : British Medical Journal·Rafael GafoorMartin C Gulliford
Jun 25, 2019·Psychotherapy and Psychosomatics·Michael P Hengartner, Martin Plöderl
Sep 15, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexander LisinskiElias Eriksson

❮ Previous
Next ❯

Citations

Jan 22, 2021·Journal of Psychiatric Research·Larry PriceRita Hitching

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.